Lv2
110 积分 2024-12-06 加入
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
17天前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
21天前
已完结
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
1个月前
已完结
Ixekizumab or secukinumab in psoriasis: what difference does it make?
2个月前
已完结
Vunakizumab: First Approval
3个月前
已完结
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
3个月前
已完结
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
3个月前
已完结
Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
3个月前
已完结
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
3个月前
已完结
Efficacy of etanercept on ankylosing spondylitis
3个月前
已完结
皖公网安备34019202002308
